多基和聚合物作为新型药物候选剂,用于对抗Plasmodium falciparum
Roshan Sivakumar1, Katherine Floyd1, Jessey Erath1
1Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, USA.
Malaria journal
|August 1, 2024
概括
新的聚氨酸在治疗疟疾方面表现有前途,通过向Plasmodium falciparum. 这些有效降低红细胞中的寄生虫水平,具有低毒性,提供潜在的新疟疾治疗方法.
科学领域:
- 生物化学 生物化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 疟疾是由Plasmodium falciparum引起的,是全球主要的健康威胁.
- 现有的基于美素的组合疗法因寄生虫耐药性增加而面临挑战.
- 调查寄生虫蛋白质组的独特特征,如聚氨酸残留物,用于新的治疗点.
研究的目的:
- 评估聚氨酸的抗疟疾潜力,以对抗红细胞内Plasmodium falciparum.
- 确定用于寄生虫抑制的聚氨酸的最佳长度和修改.
- 为了确定疟疾寄生虫中聚氨酸的特定标.
主要方法:
- 在人体红细胞中培养Plasmodium falciparum的体外培养.
- 流细胞测量分析阿克里丁色染色的寄生虫,以测量生长抑制.
- 亲和力拉下测试与质谱相结合,以确定蛋白质标.
主要成果:
- 聚氨酸在体外有效降低了寄生虫病,毒性最小.
- 治疗疗效与的长度相关,30-氨酸可以在72小时内消灭寄生虫.
- 基化和使用树突体/聚合物增强了稳定性和寄生虫清除,将外膜蛋白确定为标.
结论:
- 聚氨酸具有显著的抗疟疾活性,可以对抗Plasmodium falciparum.
- 改性聚氨酸,包括FDA批准的树枝状物,提供了一个有希望和稳定的治疗策略.
- 用基于聚氨酸的化合物向寄生虫外膜蛋白质,为疟疾治疗提供了一种新的方法.
更多相关视频
10:22Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
8.9K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
